Finance

Lists
000403:SHE
Pacific Shuanglin Bio-pharmacy Co Ltd
9,50 CN¥
-0,63%
(-0,060) 1D
16 հոկ, 15:04:24 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000403...
Open
9,62 CN¥
High
9,79 CN¥
Low
9,36 CN¥
Mkt. cap
9,22 մլրդ
Avg. vol.
5,57 մլն
Volume
6,30 մլն
P/E ratio
33,80
52-wk high
16,58 CN¥
52-wk low
8,54 CN¥
EPS
0,28 CN¥
Shares outstanding
950,40 մլն
No. of employees
3 հզր
Open
9,62 CN¥
High
9,79 CN¥
Low
9,36 CN¥
Mkt. cap
9,22 մլրդ
Avg. vol.
5,57 մլն
Volume
6,30 մլն
P/E ratio
33,80
52-wk high
16,58 CN¥
52-wk low
8,54 CN¥
EPS
0,28 CN¥
Shares outstanding
950,40 մլն
No. of employees
3 հզր
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
14 րոպե առաջ
Phase 3 Lung Trials Could Be A Big Test For Insmed (INSM)
About Pacific Shuanglin Bio-pharmacy Co Ltd
CEO-
Employees2,76 հզր
Founded1993
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
631,66 մլն
1,01 մլրդ
342,92 մլն
486,92 մլն
Cost of goods sold
345,25 մլն
674,87 մլն
223,50 մլն
333,55 մլն
Cost of revenue
345,25 մլն
674,87 մլն
223,50 մլն
333,55 մլն
Research and development expenses
12,11 մլն
25,01 մլն
10,34 մլն
6,09 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
142,84 մլն
120,55 մլն
83,99 մլն
76,71 մլն
Operating expense
161,42 մլն
162,30 մլն
98,57 մլն
90,31 մլն
Total operating expenses
506,67 մլն
837,17 մլն
322,07 մլն
423,86 մլն
Operating income
124,99 մլն
177,29 մլն
20,85 մլն
63,06 մլն
Other non operating income
-236,66 հզր
-32,79 հզր
-2,74 մլն
2,22 մլն
EBT including unusual items
138,01 մլն
93,36 մլն
29,08 մլն
69,80 մլն
EBT excluding unusual items
134,60 մլն
178,56 մլն
28,71 մլն
70,38 մլն
Income tax expense
16,43 մլն
31,33 մլն
6,34 մլն
7,56 մլն
Effective tax rate
11,90%
33,55%
21,82%
10,83%
Other operating expenses
5,57 մլն
7,62 մլն
6,17 մլն
5,92 մլն
Net income
121,39 մլն
62,09 մլն
22,97 մլն
61,33 մլն
Net profit margin
19,22%
6,12%
6,70%
12,60%
Earnings per share
-
-
-
-
Interest and investment income
15,61 մլն
6,69 մլն
15,52 մլն
11,30 մլն
Interest expense
-5,76 մլն
-5,39 մլն
-4,92 մլն
-6,20 մլն
Net interest expenses
9,85 մլն
1,29 մլն
10,60 մլն
5,09 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
155,19 մլն
210,35 մլն
53,91 մլն
100,07 մլն
Gain or loss from assets sale
785,80 հզր
-756,00 հզր
-
135,62 հզր
AI content may include mistakes. Learn more
Google Apps